Who we are
The Haematopathology and Oncology Diagnostic Service (HODS) at Cambridge University Hospitals is the Specialist Integrated Haematological Malignancy Diagnostic Service (SIHMDS) for the East of England. We provide a multi-parameter, integrated service including morphology, immunophenotyping and histopathology for the diagnosis and classification of haematological malignancies.
Our highly experienced HCPC-registered laboratory scientists work closely with a dedicated team of consultants from both a haematology and histopathology background. This integration ensures every specimen is assessed, tested, interpreted, and reported to the highest standards and also enables the continued development of high-quality clinical testing in the rapidly progressing field of molecular pathology.
Samples with a suspected or known haematological malignancy will be received at the HODS specimen reception and assessed according to the clinical details and/or morphological and flow cytometry findings. Samples are processed according to specific diagnostic pathways based on the clinical presentation, morphological assessment, and known or suspected diagnosis.
For cases requiring cytogenetic or molecular testing, these will be performed in partnership with the Eastern Genomic Laboratory Hub (GLH) located on the Cambridge University Hospital site, from whom the services are commissioned by NHS England.